Twice-Daily Dosing Of Xibrom(TM) As Equivalent To Four Times A Day Of Other Treatments, Study

Fri, 05 May 2006 11:00 AM EST

... ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA) announced today the presentation of data from aphysician- sponsored clinical trial designed to compare the efficacy ofXibrom(TM) (bromfenac ophthalmic solution) 0.09% with two topicalnon-steroidal anti- inflammatory solutions (NSAIDs) that were given fourtimes a day for the treatment of acute pseudophakic cystoid macular edema(CME)... click link for more info. ...